Pharmacotherapy of sepsis

Critical Care Nursing Quarterly
David J PavlikLauren Finoli

Abstract

Treatment of sepsis involves prompt recognition and treatment to optimize outcome. Several medication considerations are pertinent to patients with sepsis, severe sepsis, and septic shock. Medications play a crucial role in providing resuscitation, hemodynamic support, resolution of infection, and reduction of complications of the disease. Over the past 20 years, significant focus has been devoted to the pharmacologic treatment of septic shock, resulting in significant advances and controversies. Ongoing research will continue to focus on this disease process and will continue to shape treatment in the future. The use of medication therapies directed at treatment of sepsis will be reviewed in this article.

References

Oct 19, 1995·The New England Journal of Medicine·L GattinoniR Fumagalli
Nov 2, 1994·JAMA : the Journal of the American Medical Association·P E Marik, M Mohedin
Jun 16, 1994·The New England Journal of Medicine·M A HayesD Watson
Sep 1, 1993·Critical Care Medicine·E RuokonenE J Hansen
Dec 10, 1998·Journal of Internal Medicine·L LeiboviciS D Pitlik
Feb 24, 2001·Critical Care Clinics·K C McCowenB R Bistrian
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Mar 15, 2002·Drugs·Katherine A Lyseng-Williamson, Caroline M Perry
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Jan 25, 2003·Critical Care Medicine·E Wesley ElyUNKNOWN PROWESS Investigators
Apr 20, 2004·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Management Guidelines Committee
May 28, 2004·The New England Journal of Medicine·Simon FinferUNKNOWN SAFE Study Investigators
Sep 30, 2005·The New England Journal of Medicine·Edward AbrahamUNKNOWN Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group
Feb 3, 2006·The New England Journal of Medicine·Greet Van den BergheRoger Bouillon
Apr 21, 2006·The New England Journal of Medicine·Kenneth P SteinbergUNKNOWN National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network
Feb 28, 2007·Intensive Care Medicine·Steffen Weber-CarstensDidier Keh
Jul 28, 2007·Pharmacotherapy·Manjunath P Pai, David T Bearden
Jan 11, 2008·The New England Journal of Medicine·Charles L SprungUNKNOWN CORTICUS Study Group
Jan 11, 2008·The New England Journal of Medicine·Frank M BrunkhorstUNKNOWN German Competence Network Sepsis (SepNet)
Feb 29, 2008·The New England Journal of Medicine·James A RussellUNKNOWN VASST Investigators
Mar 26, 2009·The New England Journal of Medicine·Simon FinferJuan J Ronco
Jun 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Wendy I SliglSumit R Majumdar
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Djillali AnnaneG Umberto Meduri
Oct 31, 2009·Lancet·Matthew E Falagas, Drosos E Karageorgopoulos
Mar 5, 2010·The New England Journal of Medicine·Daniel De BackerUNKNOWN SOAP II Investigators
Jun 18, 2011·American Journal of Respiratory and Critical Care Medicine·Gourang P Patel, Robert A Balk
May 24, 2012·The New England Journal of Medicine·V Marco RanieriUNKNOWN PROWESS-SHOCK Study Group
Oct 9, 2012·Current Opinion in Infectious Diseases·Brett Janson, Karin Thursky
Oct 18, 2012·JAMA : the Journal of the American Medical Association·Nor'azim Mohd YunosMichael Bailey
Nov 8, 2012·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Constance Biggar, Cynthia Nichols
Jan 29, 2013·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
Sep 27, 2013·The New England Journal of Medicine·John A Myburgh, Michael G Mythen
Oct 11, 2013·JAMA : the Journal of the American Medical Association·Djillali AnnaneUNKNOWN CRISTAL Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved